News

January 18, 2011 – Epicardial ablation device vendor nContact Inc. said data presented by physicians in two posters at the 17th Annual International Boston Atrial Fibrillation Symposium may change how physicians think about treating atrial fibrillation (AF) patients with enlarged atria.

Home January 18, 2012
Home
News

January 18, 2012 — Baptist Cardiac & Vascular Institute of Miami announced a partnership with the University of Heidelberg, one of the largest and most important centers for patient care, medical research and teaching in Europe, for hands-on access to the latest medical innovations.

Home January 18, 2012
Home
News

January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating positive outcomes for the Epic self-expanding nitinol stent in patients with iliac artery disease.

Home January 18, 2012
Home
News

January 18, 2012 — PLC Systems Inc. announced that final results from the MYTHOS investigator-sponsored clinical trial of RenalGuard in Italy have been published in the January 2012 issue of Journal of the American College of Cardiology – Cardiovascular Interventions, a peer-reviewed journal of the American College of Cardiology. The results from this trial showed RenalGuard as better than the current standard-of-care at reducing rates of contrast-induced nephropathy (CIN) and in-hospital dialysis in at-risk patients undergoing certain imaging procedures.

Home January 18, 2012
Home
News

January 17, 2012 – Terumo Americas Holding Inc., a U.S. subsidiary of Japan's Terumo Corp., announced it acquired Onset Medical Corp., which develops interventional procedural access sheath technology for cardiology and urology.

Home January 17, 2012
Home
News

January 17, 2012 – Nonstop nosebleeds can be serious and frightening, often sending people to the emergency room, where their noses are packed with gauze. When that doesn’t work, nosebleeds can be halted by injecting microscopic particles – made of the same material as a kitchen sponge – into the arteries that supply the nose.

Home January 17, 2012
Home
News

January 17, 2012 — Killing tumors by freezing them can add precious time to the lives of women with ovarian cancer that has spread to other parts of the body. Minimally invasive cryoablation extends lives and is cost-effective, according to a study being presented at the 4th annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

Home January 17, 2012
Home
News

January 17, 2012 — The U.S. Food and Drug Administration (FDA) expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection).

Home January 17, 2012
Home
News

January 16, 2012 — Endosense has announced the European launch of the TactiCath 75 force-sensing ablation catheter as well as results of the EFFICAS clinical study of contact force-sensing in catheter ablation procedures.

Home January 16, 2012
Home
News

January 16, 2012 — Philips Healthcare announced the enrollment of the first patients in its CHILL-MI clinical study. The RAPID MI-ICE trial showed a 38 percent reduction in infarct size in STEMI patients who were cooled to a temperature of less than 35° C prior to performing angioplasty.

Home January 16, 2012
Home
Technology

January 12, 2012 — Clinical analytics company Humedica announced the launch of a predictive analytic model that identifies patients at high-risk for a congestive heart failure (CHF) hospitalization.

Home January 13, 2012
Home
News

January 13, 2012 — Amorcyte Inc., a NeoStem Inc. company, announced the expansion of intellectual property protection around its lead product candidate, AMR-001, with the grant of U.S. patent number 8,088,370 by the United States Patent and Trademark Office. Amorcyte's first issued patent (7,794,705) entitled "Compositions and Methods of Vascular Injury Repair," protects a chemotactic stem cell product enriched for CD34+ cells that treats injury from acute myocardial infarction (AMI). The new patent covers the use of AMR-001 in the repair of any vascular injury caused by vascular insufficiency, and effectively expands the breadth of the patented claims beyond the current target indications for AMR-001.

Home January 13, 2012
Home
News

January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82 last July by the manufacturer, Bracco Diagnostics. CardioGen-82 consists of a generator that is used at clinical sites to produce rubidium (Rb)-82 chloride injection. A CardioGen-82 positron emission tomography (PET) scan is one of a variety of nuclear medicine scans that use radioactive drugs to evaluate myocardial perfusion.

Home January 13, 2012
Home
healthcare spending
Feature

January 12, 2011 – U.S. healthcare spending experienced historically low rates of growth in 2009 and 2010 according to the annual report of national health expenditures (NHE) published in the January issue of the journal Health Affairs.

Home January 12, 2012
Home
News

January 12, 2012 – Geoffrey A. Rose, M.D., FASE, FACC, was recently appointed chairperson of the Intersocietal Accreditation Commission (IAC). Headquartered in Ellicott City, Md., the IAC is a national, nonprofit organization in operation to evaluate and accredit medical facilities.

Home January 12, 2012
Home
Subscribe Now